Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial.

Abstract

OBJECTIVE The purpose of our study was to evaluate the effects of three dosages of transdermally administered 17 beta-estradiol on markers of bone loss in women who had recently undergone surgical menopause. STUDY DESIGN This was a 2-year, randomized, double-blind, placebo-controlled study that reviewed 127 women stratified by age. Biochemical indicators… (More)

Topics

Cite this paper

@article{Field1993PreventiveEO, title={Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial.}, author={Cytohistology Andrew S. Field and Steven J. Ory and Heinz W. Wahner and Rebekah R. Herrmann and Howard L Judd and B. Lawrence Riggs}, journal={American journal of obstetrics and gynecology}, year={1993}, volume={168 1 Pt 1}, pages={114-21} }